Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers

July 6, 2018

Sanofi and Lead Pharma Holding patent RORC modulators

July 5, 2018

Aslan Pharmaceuticals submits clinical trial authorization

July 4, 2018

LEO Pharma initiates phase I study of LEO-138559

July 2, 2018

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

June 29, 2018

Aclaris reports promising interim data from phase II trial of ATI-501 in severe alopecia areata

June 29, 2018

ProQR initiates phase I/II WINGS trial of QR-313

June 29, 2018

Gachon University, Seoul National University identify SIRT1 activators

June 28, 2018

Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis

June 27, 2018

Clinuvel files NDA for Scenesse for erythropoietic protoporphyria

June 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...